Bone Biologics Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Walsh Deina H, was filed 14 Sept 2023.
Since the insiders bought
- -67.1%Entry US$34.51 · Close at T+365 US$11.34
- -77.5%Entry US$31.78 · Close at T+365 US$7.14
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2022FY ended December 2022 · cache
- 8,000 shares@ US$0.6496.1% of flowCommon StockSEC:0001493152-23-032583:0Canonical exit: 12 Dec 2023 (T+90)
- 9,500 shares@ US$0.687456.8% of flowCommon StockSEC:0001493152-23-032321:0Canonical exit: 10 Dec 2023 (T+90)
- 6,700 shares@ US$0.7147.2% of flowCommon StockSEC:0001493152-23-031935:1Canonical exit: 5 Dec 2023 (T+90)
- 300 shares@ US$0.703.9% of flowCommon StockSEC:0001493152-23-031935:0Canonical exit: 5 Dec 2023 (T+90)
- 7,600 shares@ US$0.660543.2% of flowCommon StockSEC:0001493152-23-031680:0Canonical exit: 29 Nov 2023 (T+90)
- 500,137 shares0Common StockSEC:0001493152-23-009491:0
- 9,361,702 shares0Common StockSEC:0001493152-21-025816:1
- 476,190 shares@ US$5.24Common StockSEC:0001493152-21-025816:2
- 1,004,310 shares0Common StockSEC:0001493152-21-025816:3
- 5,928,774 shares@ US$2.50100.0% of flowCommon StockSEC:0001493152-21-025816:0
- 195,000 shares@ US$1.001.3% of flowCommon StockSEC:0001493152-20-000773:0Canonical exit: 1 Apr 2020 (T+90)
- 195,000 shares@ US$1.00100.0% of flowCommon StockSEC:0001493152-20-000776:0Canonical exit: 1 Apr 2020 (T+90)
- 553,191 shares0Common StockSEC:0001493152-19-011866:0Canonical exit: 4 Nov 2019 (T+90)
- 553,191 shares0Common StockSEC:0001493152-19-011867:0Canonical exit: 4 Nov 2019 (T+90)
- 85,106 shares0Common StockSEC:0001493152-19-010727:0Canonical exit: 13 Oct 2019 (T+90)
- 85,106 shares0Common StockSEC:0001493152-19-010724:0Canonical exit: 13 Oct 2019 (T+90)
- 1,063,830 shares0Common StockSEC:0001493152-19-009559:0Canonical exit: 18 Sept 2019 (T+90)
- 1,063,830 shares0Common StockSEC:0001493152-19-009561:0Canonical exit: 18 Sept 2019 (T+90)
- 1,063,830 shares0Common StockSEC:0001493152-19-008226:0Canonical exit: 5 Aug 2019 (T+90)
- 1,063,830 shares0Common StockSEC:0001493152-19-008227:0Canonical exit: 5 Aug 2019 (T+90)
- 18,009,696 shares0Common StockSEC:0001493152-19-003934:0Canonical exit: 17 Mar 2019 (T+90)
- 1,489,362 shares0Common StockSEC:0001493152-19-003934:1Canonical exit: 23 Jun 2019 (T+90)
- 18,009,696 shares0Common StockSEC:0001493152-19-003931:0Canonical exit: 17 Mar 2019 (T+90)
- 1,489,362 shares0Common StockSEC:0001493152-19-003931:1Canonical exit: 23 Jun 2019 (T+90)
- 1,826,779 shares0Common StockSEC:0001615774-17-007141:0
25 of 75 declarations
About Bone Biologics Corp
On January 2, 2020, Don Hankey, Chairman of the Board, and Bret Hankey, Director, each bought for EUR 173,784, most of the EUR 367,673 gathered by the 20 purchases at Bone Biologics Corp, only 7 of which have a known amount (median EUR 4,770). Don Hankey signs 12 of the 38 filings, including 7 purchases; Bret Hankey has 7 purchases across 7 filings. Jeff Frelick, Chief Executive Officer, bought for EUR 6,074 on September 11, 2023, in the window from August 31 to September 13, 2023 when 2 insiders bought for EUR 20,105. The 2 sales are the oldest on file: EUR 7,636 for B. Chia Soo, Director, and EUR 3,818 for Benjamin Wu, Director, both on December 22, 2015. Purchases are 91% of open-market trades. AFH Holding & Advisory, LLC (5 filings) and Amir F. Heshmatpour (4), both 10% Owner, neither bought nor sold. For transactions from December 22, 2015 to September 13, 2023, there are also 13 filings of another kind and 3 grants from 11 filers, with a peak of 12 in 2019, published a median of 4 days after the trade. The US healthcare and pharma company has no filing in the last twelve months.
